Similar recurrence rates seen after curettage with local adjuvants for giant cell tumor of bone

http://www.healio.com/orthopedics/oncology/news/online/%7Bb3b3f1b2-bdc0-405d-87b4-1552b0fa92e0%7D/similar-recurrence-rates-seen-after-curettage-with-local-adjuvants-for-giant-cell-tumor-of-bone

Similar recurrence rates seen after curettage with local adjuvants for giant cell tumor of bone

van der Heijden L. J Bone Joint Surg Am. 2014;doi:10.2106/JBJS.M.00516.

• March 19, 2014

Function and recurrence rates were similar between patients with giant cell tumors of bone treated with combinations of either phenol and polymethylmethacrylate, liquid nitrogen and polymethylmethacrylate or liquid nitrogen and bone grafts.

“Treatment of giant cell tumor of bone remains challenging, as recurrence rates remain relatively high after curettage with local adjuvants,” the authors wrote in the study. “Functional outcome was excellent in all cohorts, making the relatively high recurrence rates acceptable.”

Disclosures: van der Heijden, van der Geest, Schreuder and van de Sande have no relevant financial disclosures. Dijkstra receives payments for lectures from Boerhaave Congress, Medtronic and Stryker.